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Abstract
The potential of natural products to prevent obesity have been investigated, with evidence
to suggest that chitosan has anti-obesity effects. The current experiment investigated the
anti-obesity potential of prawn shell derived chitosan on a range of variables relevant to
obesity in a pig model. The two dietary treatment groups included in this 63 day study were:
T1) basal diet and T2) basal diet plus 1000 ppm chitosan (n = 20 gilts per group (70 ± 0.90
kg). The parameter categories which were assessed included: performance, nutrient digest-
ibility, serum leptin concentrations, nutrient transporter and digestive enzyme gene expres-
sion and gut microbial populations. Pigs offered chitosan had reduced feed intake and final
body weight (P< 0.001), lower ileal digestibility of dry matter (DM), gross energy (GE) (P<
0.05) and reduced coefficient of apparent total tract digestibility (CATTD) of gross energy
and nitrogen (P<0.05) when compared to the basal group. Fatty acid binding protein 2
(FABP2) gene expression was down-regulated in pigs offered chitosan (P = 0.05) relative to
the basal diet. Serum leptin concentrations increased (P< 0.05) in animals offered the chito-
san diet compared to pigs offered the basal diet. Fatness traits, back-fat depth (mm), fat
content (kg), were significantly reduced while lean meat (%) was increased (P<0.05) in chit-
osan supplemented pigs. Pigs offered chitosan had decreased numbers of Firmicutes in
the colon (P <0.05), and Lactobacillus spp. in both the caecum (P <0.05) and colon (P
<0.001). Bifidobacteria populations were increased in the caecum of animals offered the
chitosan diet (P <0.05). In conclusion, these findings suggest that prawn shell chitosan has
potent anti-obesity/body weight control effects which are mediated through multiple biologi-
cal systems in vivo.
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Introduction
The potential of natural products for preventing obesity is now being investigated, due to syn-
thetic compounds having some harmful side effects. Chitosan, is a non-toxic, natural polysac-
charide composed of randomly distributed β-(1–4)-linked d-glucosamine and N-acetyl-d-
glucosamine and has been shown to control body weight [1, 2]. The control of body weight is
influenced primarily by three interrelated factors; food intake, nutrient absorption and body fat
stores [3]. Studies have shown that dietary supplementation of chitosan reduces feed intake in
both mice [4] and pigs [2] and has been associated with an increase in serum leptin levels. Lep-
tin, a hormone produced by adipocytes has been shown to play a key role in appetite suppression
[5]. While the anti-obesity effects of chitosan are thought to originate from its lipid-binding
properties [6] other mechanisms are also worthy of exploration. Chitosan alters gut microbial
populations as evidenced by measurable effects on odour emissions in pigs [7]. Hence other
anti-obesity effects of chitosan may be mediated through the modulation of gut microbiota [7, 8]
and subsequent alterations to nutrient absorption which favour a leaner body weight.
Reports that obesity is associated with alterations to the gut microbiota suggest a potential
connection between specific microbial taxa and this disorder [9]. The predominant phyla in
the large intestine (Firmicutes, Bacteroidetes and Actinobacteria) have an important role in the
fermentation of non-digestible carbohydrates which are broken down into short chain fatty
acids, the quantities of which are linked to obesity [10].
Nutrient digestibility is an important determinant in identifying the volume of nutrients
absorbed by a host. Walsh et al. [2] demonstrated that dietary supplementation of chitosan
increased faecal fat excretion, suggesting that there was reduced lipid absorption. The small intes-
tine is the primary site for fat absorption and transport. Following nutrient breakdown by diges-
tive enzymes, nutrient transporters facilitate the absorption of nutrients into the blood stream
[11]. At this point, these nutrient transporters act as the gatekeepers of overall nutrient status
and subsequent growth and development of the animal [12]. Non-optimal changes to both gene
expression and activity of nutrient transporters and/or the gut microbial populations have been
implicated in both restricted and excessive growth [12, 13]. Such changes may underpin the
reported anti-obesogenic properties of chitosan, subsequently altering nutrient availability.
The objective of the present study was to investigate the effects of dietary supplementation
of chitosan on performance, nutrient digestibility, serum leptin concentrations, nutrient trans-
porter and digestive enzyme gene expression and gut microbial populations using a pig model.
The hypothesis is that dietary supplementation of chitosan will reduce dietary intake, body
weight and carcass fat content with a down-regulation of long chain fatty acid transporter and
digestive enzyme gene expressions, while altering gut microbial populations in favour of a
leaner body weight.
Materials and Methods
All experimental procedures described in this experiment were approved under University
College Dublin animal research ethics committee (AREC) and conducted under experimental
license from the Irish Department of Health in accordance with the Cruelty to Animals Act
1876 and the European Communities (Amendments of the Cruelty to Animals Act, 1876) Reg-
ulations (1994).
Generation of chitosan from chitin
The chitosan was generated from prawn (Nephrops norvegicus) shell sourced from Spiddal, Co.
Galway, Ireland. Prawn shell was collected on five separate occasions before chitosan extraction
was carried out. The prawn shell was heated in boiling sodium chloride (4% NaCl) for 10 min
Chitosan Influences Nutrient Digestibility and Microbial Populations
PLOS ONE | DOI:10.1371/journal.pone.0144127 December 4, 2015 2 / 16
and cooled in tap water to remove excess prawn protein material. The shell was washed exten-
sively and freeze-dried. Clean, dry shell was milled, sieved and subsequently demineralised and
deproteinised using a BioFlo 110 Modular Bioreactor (New Brunswick Scientific, USA). Fol-
lowing this, HCL (0.25 M) was added to the prawn shell material at a ratio of 1:40 weight/vol-
ume to demineralise the shell. The temperature of the reaction was maintained at 40°C for 6 h.
The shell material was subsequently drained, washed until a neutral pH was obtained, then fro-
zen and freeze-dried to obtain a demineralised shell powder. The demineralised shell powder
was then deproteinised using 0.25 M NaOH using a shell to solvent ratio of 1:40 w/v at 70°C
for 6 h. The chitosan was washed until a neutral pH was reached, then freeze-dried and subse-
quently milled to obtain chitosan powder.
Characterisation of chitosan
The molecular weight data for the extracted chitosan was analysed using the SEDFIT-MSTAR.
The degree of acetylation was determined by analysis of the 1H proton spectrum following the
method of Muzzarelli et al. [14].
Animals and management
The experiment was a complete randomised design. Forty females pigs (Large White x Landrace
genetic lines, Hermitage, Co. Kilkenny, Ireland), with average body weight of 70 kg, SD = 0.9,
were randomly assigned to one of two dietary treatments (20 animals/treatment): (T1) basal
diet (control) and (T2) basal diet plus 1000 ppm chitosan. Female pigs were used because of
their higher back fat deposition relative to male pigs [15]. The concentration of chitosan used in
the present study was based on previous work byWalsh et al. [2]. The diets were provided ad
libitum in a meal form and water was available ad libitum from nipple drinkers. The diets were
formulated to have similar digestible energy (14 MJ/kg) and standardised ileal digestible lysine
(8.5 g/kg) contents. All amino acid requirements were met relative to lysine [16]. Detailed ingre-
dient composition and chemical analysis of the diets are presented in Table 1.
The animals were penned in four groups of ten with a space allowance of 0.75m2 per pig.
The pens were equipped with single space computerised feeders (Mastleistungsprufung
MLP-RAP; Schauer Agrotronic AG, Sursee, Switzerland), as described by Varley et al. [17] and
Walsh et al. [2] which allowed individual ad libitum feeding and daily recording of dietary
intake. Briefly, when the animal entered the feeder, it was recognised by the electronic system
(MLP-Manager 1.2; Schauer Maschinenfabrik Ges.m.b.H and CoKG, Prambachkirchen, Aus-
tria). Each animal was ear-tagged with a uniquely coded transponder and the identification cir-
cuit recorded the number of the animal. When the animal finished feeding and withdrew from
the trough, the electronic system recorded the difference between the pre- and post-visit trough
weight and the data was stored in a file with the number of identification of the animal, the
date, and the time of entry and exit. The animals were weighed at the beginning of the experi-
ment (day 0) and every two weeks up to slaughter (day 63).
Feed samples were collected weekly and stored at -20°C for chemical analysis. Celite (300
mg/kg) was added to the feed at manufacture in order to measure the coefficient of apparent
ileal digestibility (CAID) and coefficient of apparent total tract digestibility (CATTD) using the
acid insoluble ash technique [18]. Faecal samples were collected daily from each animal during
days 28–30 to measure the CATTD using the acid insoluble ash technique.
Blood sample collection
Blood samples (10 ml) were collected from each animal from the vena jugularis by puncture
into vacutainers (Becton, Dickinson, Drogheda, Ireland) on day 0 (prior to commencing of the
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experiment), day 14, 28, 37, 49 and 63 to facilitate leptin quantification. Blood samples were
allowed to clot at 4°C and serum was collected after centrifugation (1,500 × g for 15 min at
4°C). Serum samples were stored at -20°C until analysis.
Post slaughter sample collection
On day 63, all animals were slaughtered after stunning with carbon dioxide and the entire
digestive tract was removed by blunt dissection. Digesta samples were recovered aseptically
from the ileum in a section approximately 30 cm in length from the ileo-caecal valve, in order
to measure the CAID of nutrients. Digesta sample was collected from the caecum and the sec-
ond loop of the ascending colon, using sterile instruments. Digesta samples were stored at
-20°C in separate, sterile containers (Sarstedt) for further volatile fatty acids (VFA) (colon) and
microbial (caecum and colon) analysis. Tissue samples from the duodenum (10 cm from the
Table 1. Composition and chemical analysis (g/kg, unless otherwise indicated).
Ingredient (g/kg) T1 T2
Wheat 382.6 382.6
Barley 250.0 250.0
Soya bean meal 170.0 170.0
Maize 150.0 150.0
Soya oil 18.0 18.0
Limestone 12.5 12.5
Salt 5.0 5.0
Monocalcium phosphate 6.6 6.6
Vitamins and minerals premixa 2.5 2.5
Lysine HCL 2.3 2.3
L-threonine 0.5 0.5
Chitosan 0 1.0
Analysis (g/kg, unless otherwise stated)
Dry matter 857.6 856.4
Crude protein (N X 6.25) 177.9 177.7
Ash 42.5 42.8
Gross energy (MJ/kg) 15.9 15.7
Neutral detergent ﬁbre † 130.5 130.3
Lysine† 9.2 9.1





T1, basal diet; T2, basal diet plus 1000 ppm chitosan.
a The premix provided vitamins and minerals (per kg diet) as follows: 4.2 mg of retinol, 0.07 mg of
cholecalciferol, 80 mg of α-tocopherol, 120 mg of copper as copper sulphate, 100 mg iron as ferrous
sulphate, 100 mg of zinc as zinc oxide, 0.3 mg of selenium as sodium selenite, 25 mg of manganese as
manganous oxide, 0.2 mg of iodine as calcium iodate on a calcium sulphate/calcium carbonate carrier, 2
mg of thiamine, 15 μm of cyanocobalamin, 7 mg of pantothenic acid, 2 mg of riboﬂavin, 7 mg of niacin, 3
mg of adenine and 100 mg of phytase (Natuphos) (Nutec, Co. Kildare, Ireland).
† Calculated for tabulated nutritional composition [19].
doi:10.1371/journal.pone.0144127.t001
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stomach), jejunum (60 cm from the stomach) and ileum (10 cm from the ileo-cecal valve) were
collected to analyse the gene expression of nutrient transporters and digestive enzymes. Tissue
samples were emptied and cleaned by dissecting along the mesentery and rinsing using sterile
PBS (Oxoid) as described previously [20, 21]. Tissue sections of 1 cm2, which had been stripped
of the overlying smooth muscle were cut from the tissue and stored in RNAlater™ solution
(Ambion Inc, Austin, TX) overnight at 4°C. The RNAlater™ was then removed and the tissue
sample was stored at -70°C until RNA extraction.
Carcass analysis
Backfat thickness was measured at 6 cm from the edge of the split back at the level of the third
and fourth last ribs using the Hennessy grading probe (Hennessy and Chong, Auckland, New
Zealand). The lean meat content (g/kg) was estimated according to the following formula [2]:
Estimate lean meat content ðg=kgÞ¼ 543:1  7:86x þ 2:66y
Where x is fat depth (mm) and y is muscle depth (mm).
Further carcass data were determined using the following equations:
Carcass weight ðkgÞ¼ hot carcass weight x 0:98:
Killout proportion ð%Þ¼ carcass weight= body weight ðBWÞ:
Estimated ash content ¼ 3% of carcass weight
[22].
Carcass fat content ¼ carcass weight  ðlean þ ash content of carcassÞ:
Laboratory analysis
Leptin quantification
Serum leptin was quantified by using a specific pig leptin enzyme-linked immunosorbent assay
(ELISA) kit from Life Science Inc. (Wuhan, China) according to the manufacturer’s instruc-
tions. Sensitivity of the assay was 0.114 pg/ml and intra-assay coefficient of variation
was< 12%. Absorbance was measured at 450 nm against 570 nm for each assay by using the
ELISA plate reader. All samples were assayed in triplicate in the same assay.
Chemical analyses
Feed, faecal and digesta samples were analysed for nitrogen (N), dry matter (DM), ash, gross
energy (GE), neutral detergent fibre (NDF) and oil. The DM content of the feed, faeces and
digesta were determined after drying for 72 h at 55°C. The crude ash content of diets, faeces
and digesta was determined after ignition of a weighed sample in a muffle furnace
(Nabertherm, Bremen, Germany) at 550°C for 6 h. The GE of diets, faeces and digesta samples
was determined using an adiabatic bomb calorimeter (Parr Instruments, IL, USA). The N con-
centration of diets, faeces and digesta was determined using a LECO FP 528 instrument (Leco
Instruments, U.K. Ltd, Stockport, Cheshire, UK). The oil content was determined using the
Ether Extract Method B [23]. The acid insoluble ash content of feeds, faeces and digesta was
determined according to the method of McCarthy et al. [18]. Concentration of VFA was deter-
mined with minor adaptations as described previously by O’ Connell et al. [24].
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Extraction and quantification of microbial DNA from caecum and colon
Microbial genomic DNA was extracted from digesta samples from the caecum and colon
using a QIAamp DNA stool kit (Qiagen) in accordance with the manufacturer’s instructions.
The quantity and quality of DNA were assessed using a Nanodrop apparatus (ND1000,
Thermo Scientific). For the quantitative PCR (QPCR), standard curves were prepared with
pooled aliquots of faecal DNA as described previously [25] and used for the absolute quantifi-
cation of bacteria [26]. Genus- and species- specific primers (Table 2) were used for the esti-
mation of selected bacterial groups based on gene copy number (GCN) in the faecal matter
using QPCR on the ABI 7500 QPCR System (Applied Biosystems Limited). For bacterial
groups, QPCR was carried out in a final reaction volume of 20 μl containing 1 μl of template
DNA, 1μl of forward and reverse primers (100 pM), 10 μl of SYBR Green PCR Master Mix
(Applied Biosystems Limited) and 8 μl of nuclease-free water. The thermal cycling conditions
involved an initial denaturation step at 95°C for 10 min followed by 40 cycles of 95°C for 15 s
and 65°C for 1min. Dissociation analyses of the QPCR products were carried out to confirm
the specificity of the resulting QPCR products. All samples were prepared in duplicate. The
mean threshold cycle values from the duplicate of each sample were used for calculations.
The estimates of GCN for select bacteria were log-transformed, and they are presented as
GCN/g digesta.
Volatile fatty acid analysis
Digesta samples collected from the colon were mixed with sodium benzoate and phenyl-
methylsulfonyl fluoride to stop any bacterial activity and minimise the effects of post-thaw-
ing fermentation which would influence final VFA concentrations. A 1.0 g sample was
diluted with distilled water (2.5 × weight of sample) and centrifuged at 1,400 × g for 4 min at
20°C. One millilitre of the subsequent supernatant and 1 mL of internal standard (0.5 g of
3-methyl-n-valeric acid in 1 L of 0.15 mol/L oxalic acid) were mixed with 3 mL of distilled
water. After centrifugation to remove the precipitate, the sample was filtered through What-
man 0.45-μm polyethersulfone membrane filters into a chromatographic sample vial. A
1.0 μL quantity was injected into a model 3800 Varian gas chromatograph with a 25 m × 0.53
mm i.d. megabore column (coating CP-Wax 58 (FFAP) CB; Model CP7614, Varian, Middel-
burg, the Netherlands).
Table 2. Swine-specific primers used for real-time PCR.
Gene Primer (5'! 3') Product Length Tm (°C)
Bacteriodes F: AACGCTAGCTACAGGCTT 276 54
R: CAAATGTGGGGGACCTTC
Firmicutes F: GGAGYATGTGGTTTAATTCGAAGCA 126 59
R: AGCTGACGACAACCATGCAC
Lactobacillus F: TGGATCACCTCCTTTCTAAGGAAT 340 55
R: TGTTCTCGGTTTCATTATGAAAAAATA
Biﬁdobacteria F: GCG TGC TTA ACA CAT GCA AGT C 129 55
R: CAC CCG TTT CCA GGA GCT ATT
Enterobacteria F: CATTGACGTTACCCGCAGAAGAAGC 190 58
R: CTCTACGAGACTCAAGCTTGC
doi:10.1371/journal.pone.0144127.t002
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Nutrient transporter and digestive enzyme gene expression—RNA
extraction, complementary DNA synthesis and quantitative PCR
Total RNA was extracted using Trizol™ and further purified using the GenElute™Mammalian
Total RNAMiniprep Kit (Sigma-Aldrich, Corporation) according to the manufacturer's
instructions. Total RNA samples were treated with DNase I (Sigma-Aldrich).
Total RNA was quantified using a NanoDrop-ND1000 spectrophotometer (Thermo Fisher
Scientific, Inc.). RNA integrity was assessed on the Agilent 2100 Bioanalyzer version A.02.12
(Agilent Technologies, Inc.) and all RNA integrity number (RIN) values were> 8.9. Comple-
mentary DNA (cDNA) was synthesised from 1 μg of total RNA using the Superscript™ III
First-Strand Synthesis Kit (Thermo Scientific) and oligo (dt) primers following the manufac-
turer's instructions. The final reaction volume of 20 μl was then adjusted to 120 μl using nucle-
ase-free water. The quantitative PCR (QPCR) assay mixtures were prepared in a total volume
of 20 μl, containing 10 μl Fast SYBR PCR Master Mix (Applied Biosystems, Foster City, CA,
USA), 1.8 μl forward and reverse primer mix (300 nM), 5.7 μl nuclease-free water and 2.5 μl
cDNA. The QPCR was carried out in duplicate on the 7500 ABI Prism Sequence Detection Sys-
tem (Applied Biosystems, Foster City, CA, USA). Thermocycling conditions were as follows:
95°C for 10 min for one cycle, followed by 95°C for 15 s and 60°C for 1 min for forty cycles.
Dissociation analyses of the QPCR products confirmed the specificity of all targets. All primers
for the selected nutrient transporters: glucose transporter 1 (GLUT1/ SLC2A1), GLUT2/
SLC2A2, GLUT5, GLUT7, sodium-glucose linked transporter 1 (SGLT1/ SLC5A1), fatty acid
binding protein 2 (FABP2/I-FABP2), cluster of differentiation 36 (CD36/FAT) and peptide
transporter 1 (PEPT1/ SLC15A1), and digestive enzymes: lipase and maltase are presented in
Table 3. All primers were designed using the Primer Express™ Software (Applied Biosystems,
Foster City, CA, USA) and synthesised by MWG Biotech (Milton Keynes, Buckinghamshire,
UK). All samples were prepared in duplicate. The mean cycle threshold values of duplicates of
each sample were used for calculations. The optimal number of reference targets were
Table 3. Swine-specific primers used for real-time PCR.
Gene Accession no. Primer (5'! 3') Product Length Efﬁciency %
SGLT1 NM_001164021.1 F; GGCTGGACGAAGTATGGTGT
R; ACAACCACCCAAATCAGAGC 153 90
PEPT1 NM_214347.1 F; GGATAGCCTGTACCCCAAGCT
R; CATCCTCCACGTGCTTCTTGA 73 98
GLUT1 XM_003482115.1 F; TGCTCATCAACCGCAATGA
R; GTTCCGCGCAGCTTCTTC 61 100.90
GLUT2 AF054835.1 F: CCAGGCCCCATCCCCTGGTT
R: GCGGGTCCAGTTGCTGAATGC 96 107
GLUT5 EU012359 F: CCCAGGAGCCGGTCAAG
R: TCAGCGTCGCCAAAGCA 60 143
GLUT7 XM_003127552.3 F: ACATCGCCGGACATTCCATA
R: GCGAGGACTGCAGGAAGATC 75 106
FABP2 NM_001031780.1 F: TCGGGATGAAATGGTCCAGACT
R: TGTGTTCTGGGCTGTGCTCCA 102 98
CD36 NM_001044622.1 F:GGAGAAAAGATCACTACCATCATGAG
R: CTCCTGAAGTGCAATGTACTGACA 78 91.6
F, forward; R, reverse; SGLT, sodium-glucose linked transporter; PEPT, peptide transporter; GLUT, glucose transporter; FABP, fatty acid-binding protein;
CD36, cluster of differentiation 36.
doi:10.1371/journal.pone.0144127.t003
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identified using the geNorm application within the qbase PLUS software package (Biogazelle,
Zwijnaarde, Belgium). Briefly, the geNorm algorithm on the qbase+ package (Biogazelle, Gent,
Belgium) calculated the expression stability factor (M). From this the optimal combination of
reference genes required for normalisation were selected. Using this algorithm, reference genes
are ranked based on their M values. In brief, geNorm calculates the stability measure M for a
reference gene as the average pairwise variation (V) for that gene with all other tested reference
genes. A Vn/n+1 value is calculated for every comparison between two consecutive numbers (n
and n+1) of candidate reference genes. Following the stepwise exclusion of the least stable ref-
erence genes, by the geNorm program, M values were re-calculated and the stability series
obtained. Finally, the NF was calculated, as the geometric mean of the most stable reference
genes, and the normalised relative quantity (NRQ) of the target genes obtained as the ratio
between the relative quantities and the sample specific NF. The basic formula for relative quan-
tification (RQ = 2^ddCt) assumes 100% amplification efficiency (E = 2). The most stable
housekeeping genes for the duodenal, jejunal and ileal tissues were: peptidylprolyl isomerase A
(PPIA) and hydroxymethylbilane synthase (HMBS).
Statistical analysis
The growth performance was analysed by repeated measures analysis using the PROCMIXED
procedure of SAS [27]. The model used included pen and animal within pen as random effects.
The fixed effects were: treatment, time and interaction between treatment and time. The data
on carcass characteristics was analysed using the PROCMIXED procedure of SAS [27]. The
model used included pen and animal within pen as random effects. The fixed effect was treat-
ment. Initial body weight was used as a covariate for growth performance data. The leptin data
was analysed by repeated measures analysis using the PROCMIXED procedure of SAS [27].
The model used included the pig as a random effect. The fixed effects were: treatment, time of
sampling and the associated two way interaction between treatment and time of sampling. The
data on nutrient digestibilities, microbiology and VFA’s were analysed using the general linear
model procedure of the Statistical Analysis Systems Institute [28]. The model used included
the effect of treatment. Gene copy numbers of selected bacteria were log-transformed before
statistical analysis. The statistical model used for the nutrient transporter gene expression data
analysis included small intestinal region (duodenum vs. jejunum vs. ileum), chitosan inclusion
and interaction between region and chitosan inclusion, followed by Bonferroni's test. The
probability level that denotes significance is P< 0.05, while P values between 0.05 and 0.1 are
considered numerical tendencies. Data are presented as least-square means with their standard
errors of the means.
Results
Characterisation of prawn shell chitosan
The degree of acetylation obtained was 15%. The average molecular weight of the prawn shell
chitosan was 124,000 ± 10,000 g/mol.
Dietary intake, body weight and carcass characteristics
The effect of chitosan supplementation on body weight over time is presented in Fig 1. The
effects of chitosan supplementation on pig performance and carcass characteristics are pre-
sented in Table 4. Pigs offered the chitosan diet had lower dietary intake (P< 0.01) and body
weight gain (P< 0.05) during the experiment (days 0–63) (P< 0.01), and lower final body
weight (P< 0.05) compared with pigs offered the basal diet. There was no effect of chitosan
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inclusion on feed conversion ratio (P>0.05). Animals offered chitosan had lower backfat
depths and total carcass fat content compared to the basal group (P< 0.05). Lean meat percent-
age was higher in chitosan supplemented pigs (P<0.01) when compared to the basal group.
Coefficient of apparent ileal digestibility and coefficient of total tract
digestibility
Pigs offered the chitosan diet had decreased CAID of DM and GE (P< 0.05) compared with
the control group (Table 4). Pigs offered the chitosan diet had reduced CATTD of GE and N
compared to the control group (P< 0.05) (Table 5).
Serum leptin
There was a time effect (P<0.05) and treatment effect (P<0.05) on serum leptin concentra-
tions. Serum leptin concentrations were higher in pigs offered the chitosan diet compared with
Fig 1. Effect of dietary supplementation on body weight over time at days 0, 14, 28, 42, 56 and 63.
*P<0.05 **P<0.001 Treatment effect P< 0.001. Time effect P< 0.001. Time x treatment effect P< 0.01.
Values are means, with their standard errors represented by vertical bars.
doi:10.1371/journal.pone.0144127.g001
Table 4. Effect of dietary supplementation on growth performance and carcass characteristics (least-square means and SEM).
Performance Control Chitosan SEM P value
Dietary intake (kg/d) 2.99 2.67 0.05 0.001
Body weight gain (kg/d) 0.88 0.79 0.03 0.042
Feed efﬁciency ratio (kg/kg)†† 3.57 3.30 0.37 0.593
Carcass characteristics
Carcass weight (kg) 93.8 90.1 1.52 0.092
Kill-out proportion (%) 74.7 75.5 0.38 0.151
Back-fat depth (mm) 12.8 11.4 0.37 0.011
Fat content (kg) 36.4 33.6 0.74 0.012
Lean meat (%) 58.2 59.7 0.38 0.008
Loin eye muscle depth (mm) 55.3 57.5 1.39 0.258
SEM, standard error of mean.
†† Body weight gain/ dietary intake.
doi:10.1371/journal.pone.0144127.t004
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the basal treatment group (P< 0.05) (Fig 2). There was no interaction between time and treat-
ment on serum leptin concentrations (P> 0.05).
Nutrient transporter gene expression
The effects of chitosan supplementation on nutrient transporter gene expression are presented
in Table 6. The gene expression of FABP2 was down-regulated in animals supplemented with
chitosan compared with the basal group (Bonferroni test, P< 0.05). No supplementation effect
was observed on the gene expression of the remaining nutrient transporters (P> 0.10).
Table 5. Effect of dietary treatment on the coefficient of apparent ileal digestibility (CAID) and the
coefficient of apparent total tract digestibility (CATTD) of dry matter (DM), nitrogen (N), ash, gross
energy (GE) and crude oil (least square means and SEM).
Control Chitosan SEM P value
CAID %
DM 79.05 73.01 1.800 0.035
N 73.77 64.01 3.637 0.084
Ash 37.02 35.51 8.709 0.906
GE 78.69 72.31 1.848 0.032
CATTD %
DM 82.01 81.00 0.500 0.192
N 79.89 78.06 0.481 0.019
Ash 50.24 47.96 3.165 0.620
GE 81.30 80.25 0.354 0.050
Crude oil 78.86 77.29 1.649 0.515
SEM, standard error of the mean.
doi:10.1371/journal.pone.0144127.t005
Fig 2. Effect of dietary supplementation on serum leptin levels over time at days 0, 14, 28, 37, 49 and
63. Treatment effect (P<0.05). Time effect (P<0.05). Values are means, with their standard errors
represented by vertical bars.
doi:10.1371/journal.pone.0144127.g002
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Digestive enzyme gene expression
There was no effect of dietary supplementation on digestive enzyme gene expression in the
duodenum, jejunum and ileum (P> 0.10) (data not shown).
Microbiology
The effects of chitosan supplementation on selected microbial populations in both the caecum
and colon are presented in Table 7. Pigs offered chitosan had decreased GCN of Lactobacillus
spp. in both the caecum (P< 0.05) and colon (P< 0.001), and increased GCN of Bifidobacter-
ium in the caecum (P<0.05) compared to the control group. Animals offered chitosan had
decreased GCN of Firmicutes in the colon compared with the control group (P< 0.05). There
Table 6. Effect of dietary treatment on nutrient transporter gene expression between treatments and in the duodenum, jejunum and ileum (Relative
expressions) (least squaremeans and SEM).
Treatment Region Treatment Region
Gene Control Chitosan SEM Duodenum Jejunum Ileum SEM P value * P value *
PEPT1 1.171 1.059 0.2045 1.095 1.149 1.101 0.2496 0.6993 0.9851
SGLT1 1.694 1.072 0.2630 1.477 1.536 1.136 0.3223 0.1032 0.6275
GLUT1 0.952 0.705 0.1173 0.495 1.036 0.941 0.2553 0.1468 0.0465
GLUT2 1.406 1.012 0.2022 1.350 1.506 0.772 0.2474 0.1770 0.0896
GLUT5 1.046 1.179 0.2095 1.082 1.390 0.866 0.2566 0.6554 0.3393
GLUT7 0.996 1.470 0.2555 1.125 1.772 0.802 0.3133 0.1994 0.0865
FABP2 1.558 0.948 0.1954 1.240 1.970 0.550 0.2384 0.0336 0.0005
CD36 0.729 0.919 0.2094 0.495 1.036 0.941 0.3502 0.5237 0.3285
PEPT, peptide transporter; SGLT, sodium-glucose linked transporter; GLUT, glucose transporter; FABP, fatty acid-binding protein; CD36, cluster of
differentiation 36; SEM, standard error of mean.
*No interaction between treatment and region P> 0.05.
doi:10.1371/journal.pone.0144127.t006
Table 7. Effect of dietary supplementation on selectedmicrobial populations in the caecum and colon (GCN/g digesta) (least-square means and
SEM).
Control Chitosan SEM P value
Caecum
Bacteriodes 11.20 11.15 0.217 0.894
Firmicutes 10.95 10.87 0.111 0.639
Biﬁdobacterium 9.01 9.706 0.229 0.045
Lactobacillus spp. 11.41 10.79 0.205 0.047
Enterobacteriaceae 8.60 9.24 0.268 0.107
Colon
Bacteriodes 11.16 10.83 0.247 0.361
Firmicutes 10.93 10.64 0.076 0.015
Biﬁdobacterium 9.49 9.89 0.181 0.136
Lactobacillus spp. 11.36 10.59 0.120 0.001
Enterobacteriaceae 8.17 8.70 0.297 0.229
SEM, standard error of the mean. Gene copy number/ g digesta.
doi:10.1371/journal.pone.0144127.t007
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was no dietary supplementation effect on Bacteroidetes and Enterobacteriaceae population in
either the caecum or colon (P> 0.10).
Volatile fatty acids concentration
The effect of chitosan on volatile fatty acid concentrations is shown in Table 8. Total VFA con-
centration was increased in the colon of chitosan-supplemented animals compared with the
control group (P<0.05). Chitosan-supplemented animals had increased molar proportions of
acetate in the colon compared to the control group (P<0.05).
Discussion
The present study hypothesised that dietary supplementation of chitosan would cause a reduc-
tion in dietary intake, body weight and carcass fat content with a down-regulation of long
chain fatty acid transporter and digestive enzyme gene expressions, while altering gut microbial
populations in favour of a leaner body weight. The response observed in animals offered the
chitosan supplement, such as reduction in dietary intake and body weight gain, down-regula-
tion of FABP2 gene expression, increase in serum leptin concentration, and significant alter-
ations in gut microbial populations supports the hypothesis.
Dietary supplementation with chitosan reduced dietary intake and weight gain, similar to
findings by Walsh et al. [2]. The reduction in weight gain may be attributable to a number of
factors. Firstly, it may be due to the reduction in dietary intake observed in animals supple-
mented with chitosan with direct effects on weight gain. Secondly, the reduction in body weight
gain may be due to the increases in serum leptin concentrations which subsequently affect
appetite. The hormone leptin regulates body weight by controlling food intake and energy
expenditure [5]. The ability of leptin to regulate appetite and energy expenditure in rodents
with subsequent loss of adipose tissue has led to the description of leptin as an anti-obesity hor-
mone [29]. Thirdly, the reduced weight gain may be attributable to decreased nutrient digest-
ibility, evidenced by reductions in the CAID and the CATTD of GE. Furthermore, reduced
energy digestibility and reduced weight gain was evident in the carcass composition. The over-
all lean meat percentage was higher in chitosan supplemented animals while carcass fat content
and back fat depths were lower relative to the control group, indicating that chitosan supple-
mented animals had a lower and leaner body weight. Interestingly, while carcass fat content
and fat depths measured were lower in chitosan supplemented animals, leptin levels were high,
suggesting chitosan had a direct effect on leptin levels independent of body fat stores.
Table 8. Effect of dietary supplementation on total volatile fatty acid (VFA) concentration and proportions in the colon (least-square means and
SEM).
Molar proportions Control Chitosan SEM P value
Total VFA (mmol/g digesta) 104.8 114.8 3.44 0.050
Molar Proportions
Acetic acid 65.92 71.58 1.982 0.050
Propionic acid 20.65 23.25 1.561 0.256
Isobutyric acid 1.41 0.76 0.328 0.183
Butyric acid 13.98 14.33 1.212 0.840
Isovalaeric acid 1.30 1.08 0.120 0.215
Valeric acid 1.77 1.95 0.328 0.714
VFA, volatile fatty acids; SEM, standard error of the mean.
doi:10.1371/journal.pone.0144127.t008
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There is growing evidence that the small intestine can play an important role in the etiology
of obesity, serving as a gatekeeper at the physical interphase between the body and the diet
[30]. The small intestine is the primary site for absorption and assimilation of nutrients. In the
present study chitosan supplementation had no effect on lipase and maltase gene expression in
the small intestine, suggesting that chitosan may act only on specific cellular targets. Following
nutrient breakdown by digestive enzymes, nutrients are then transported from the extracellular
setting into the blood stream by nutrient transporters [11]. In the present study, FABP2 gene
expression was down-regulated in chitosan supplemented animals. Fatty acid binding protein
2 is responsible for the uptake of long chain fatty acids and is thought to help maintain energy
homeostasis by functioning as a lipid sensor [31]. The down-regulation of FABP2may have
reduced the absorption of lipids, thus leading to the observed reduction in body mass.
Although not significant, a numerical decrease in the CATTD of ether extract was associated
with chitosan supplemented animals. Unfortunately, due to a lack of availability of digesta, the
CAID of crude oil was not measured.
Accumulating evidence indicates that intestinal microbiota play a significant role in the
development of obesity [32, 33]. Differences in microbiota composition in the gut have been
observed between lean and obese individuals [8, 34]. The bacterial phylum Firmicutes has been
extensively researched for its role in obesity, with studies observing an increase in Firmicutes
populations in the caecum and colon of obese individuals [33, 35]. In the present study, the
GCN of Firmicutes was reduced in the colon of chitosan-supplemented animals. Although the
influence of Firmicutes on obesity is still unclear, it has been suggested that Firmicutes promote
adiposity [36]. Firmicutesmetabolise food substrates more completely [37] thereby enabling
more efficient absorption of calories and subsequent weight gain. In the present study, the
reduction in GCN of Firmicutes in the colon of chitosan-supplemented animals may partially
explain the reduction in body weight gain.
It has also been reported that Lactobacillus spp. [38] and Bifidobacterium spp. may have a
role in weight regulation [39]. The intestinal microbiota has an important role in the fermenta-
tion of non-digestible carbohydrates into short chain fatty acids. Bifidobacterium and Lactoba-
cillus are known to ferment carbohydrates to acids; Lactobacillus spp. produce lactate, and
Bifidobacterium spp. predominantly produce lactate and acetate. In the present study, GCN of
Lactobacillus spp. was decreased in the caecum and colon and GCN of Bifidobacterium spp.
was increased in the caecum of animals supplemented with chitosan. Chitosan supplementa-
tion also resulted in an increased production of acetic acid. Acetate is the main VFA produced
from the fermentation of non-digestible carbohydrates [40]. Additionally, the total VFA con-
centration was increased in the colon of animals supplemented with chitosan. Chitosan supple-
mented animals had lower CAID of DM and GE compared to the control group suggesting
there may be more material available for fermentation in the colon of chitosan supplemented
animals. An increased VFA concentration has been shown to indicate increased microbial
activity in the gastrointestinal tract [41]. Furthermore, VFAs have been suggested to regulate
insulin and glucagon secretion [40]. Glucagon and insulin are part of a feedback system that
regulates blood glucose, aiding in the control of appetite. Insulin is positively correlated with
long-term energy balance [42]. In a study using mice fed a high fat diet, with the objective to
induce obesity and diabetes, it was observed that fat mass was reduced when the diet was sup-
plemented with a Bifidobacterium strain, leading to decreased body weight gain and improved
glucose tolerance [43]. Interestingly, the present study had similar effects whereby chitosan
supplemented animals had significantly reduced weight gain and increased Bifidobacterium
abundance in the caecum when compared to the control group.
Lactobacillus spp. and Bifidobacterium spp. also function as potent probiotic agents [44].
Chitosan appears to exhibit prebiotic properties by increasing the population of
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Bifidobacterium spp. in the caecum, thus having a positive effect on gut health. However, GCN
of Lactobacillus spp. was decreased in the caecum and colon of chitosan-supplemented ani-
mals. Although Lactobacillus is considered a probiotic agent, recently, it has been suggested
that probiotics, and in particular Lactobacillus are contributing to human obesity [39]. Interest-
ingly, gut microbiota associated with obesity have been found to be enriched in Lactobacillus
and depleted in Bifidobacterium similar to the findings in the present experiment within the
control group of animals, while chitosan supplemented animals had a decrease in Lactobacillus
and an increase in Bifidobacterium populations.
In conclusion, the present study demonstrated that dietary supplementation of prawn
derived chitosan reduces feed intake and body weight in a pig model. This effect may be
orchestrated through multiple responses both within the intestinal tract and bloodstream
including; decreased nutrient digestibility, decreased FA transporter gene expression, increased
serum leptin and altered gut microflora.
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